Application 206080
- Type
- ANDA
- Sponsor
- SANDOZ INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BEPOTASTINE BESILATE | BEPOTASTINE BESILATE | SOLUTION;OPHTHALMIC | 1.5% | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bepotastine Besilate | BEPOTASTINE BESILATE | Somerset Therapeutics, LLC | cd6a061d-8ad7-4ad1-b039-1e3aa3435d32 | 2024-10-10 | Warnings, Adverse reactions | Bepotastine Besilate BEPOTASTINE BESILATE |
| Bepotastine Besilate | BEPOTASTINE BESILATE | Bausch & Lomb Americas Inc. | 70430ab5-cd0a-451e-acab-347a2f981898 | 2024-08-20 | Warnings, Adverse reactions | Bepotastine Besilate BEPOTASTINE BESILATE |
| Bepreve | BEPOTASTINE BESILATE | Bausch & Lomb Incorporated | 68bbf6a0-c4b5-47c1-8a1c-08220fbdbce6 | 2022-08-31 | Warnings, Adverse reactions | BEPOTASTINE BESILATE |
| Bepotastine Besilate | BEPOTASTINE BESILATE | Bausch & Lomb Incorporated | 995f4fe0-d861-4137-8090-a8ffc71c46f4 | 2020-12-31 | Warnings, Adverse reactions | Bepotastine Besilate BEPOTASTINE BESILATE |
| Bepotastine Besilate | BEPOTASTINE BESILATE | Mylan Pharmaceuticals Inc. | 75178670-aa57-45f9-94d5-efcf8305e683 | 2018-03-20 | Warnings, Adverse reactions | Bepotastine Besilate BEPOTASTINE BESILATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.